Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1974 1
1986 1
1987 1
1988 5
1989 5
1990 3
1991 6
1992 3
1993 1
1994 1
1995 1
1996 1
1997 3
1998 2
1999 1
2011 1
2012 2
2013 3
2014 3
2017 2
2018 2
2019 2
2021 2
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Immunological analysis of hybrid neoantigen peptide encompassing class I/II neoepitope-pulsed dendritic cell vaccine.
Morisaki S, Onishi H, Morisaki T, Kubo M, Umebayashi M, Tanaka H, Koya N, Nakagawa S, Tsujimura K, Yoshimura S, Yew PY, Kiyotani K, Nakamura Y, Nakamura M, Kitazono T, Morisaki T. Morisaki S, et al. Among authors: koya n. Front Immunol. 2023 Oct 10;14:1223331. doi: 10.3389/fimmu.2023.1223331. eCollection 2023. Front Immunol. 2023. PMID: 37881436 Free PMC article.
Efficacy of Intranodal Neoantigen Peptide-pulsed Dendritic Cell Vaccine Monotherapy in Patients With Advanced Solid Tumors: A Retrospective Analysis.
Morisaki T, Morisaki T, Kubo M, Onishi H, Hirano T, Morisaki S, Eto M, Monji K, Takeuchi A, Nakagawa S, Tanaka H, Koya N, Umebayashi M, Tsujimura K, Yew PY, Yoshimura S, Kiyotani K, Nakamura Y. Morisaki T, et al. Among authors: koya n. Anticancer Res. 2021 Aug;41(8):4101-4115. doi: 10.21873/anticanres.15213. Anticancer Res. 2021. PMID: 34281881
Contribution of pre-existing neoantigen-specific T cells to a durable complete response after tumor-pulsed dendritic cell vaccine plus nivolumab therapy in a patient with metastatic salivary duct carcinoma.
Ichimiya S, Fujimura A, Masuda M, Masuda S, Yasumatsu R, Umebayashi M, Tanaka H, Koya N, Nakagawa S, Yew PY, Yoshimura S, Onishi H, Nakamura M, Nakamura Y, Morisaki T. Ichimiya S, et al. Among authors: koya n. Immunol Invest. 2022 Jul;51(5):1498-1514. doi: 10.1080/08820139.2021.1973491. Epub 2021 Sep 5. Immunol Invest. 2022. PMID: 34486463
56 results